Metabolic syndrome and leptin are associated with adverse pathological features in male colorectal cancer patients.

Healy, L A; Howard, J M; Ryan, A M; Beddy, P; Mehigan, B; Stephens, R; Reynolds, J V

Healy, L A; Howard, J M; Ryan, A M; Beddy, P; Mehigan, B; Stephens, R; Reynolds, J V.

Affiliation

Healy LA; Department of Clinical Nutrition, St James's Hospital and Trinity College Dublin, Ireland. healyl2@tcd.ie

Colorectal Dis ; 14(2): 157-65, 2012 Feb.

Article in En | MEDLINE | ID: mdl-21689278

Subject(s)

Carcinoma/complications; Carcinoma/secondary; Colorectal Neoplasms/complications; Colorectal Neoplasms/pathology; Leptin/blood; Metabolic Syndrome/complications; Aged; Blood Pressure; Body Composition; Body Mass Index; C-Reactive Protein/metabolism; Carcinoma/blood; Cholesterol, HDL/blood; Cholesterol, LDL/blood; Colorectal Neoplasms/blood; Female; Glycated Hemoglobin/metabolism; Humans; Insulin Resistance; Intra-Abdominal Fat/diagnostic imaging; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Prospective Studies; Radiography; Sex Factors; Triglycerides/blood; Waist Circumference

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma / Colorectal Neoplasms / Leptin / Metabolic Syndrome Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google